Drug profile · INN
emapalumab-lzsg
GAMIFANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
emapalumab-lzsg (GAMIFANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN emapalumab-lzsg
Brand GAMIFANT
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is emapalumab-lzsg?
emapalumab-lzsg (GAMIFANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for emapalumab-lzsg?
GAMIFANT is a marketed brand name for emapalumab-lzsg. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of emapalumab-lzsg?
emapalumab-lzsg has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.